| 6ZOV | date | ![]() |
|||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| authors | |||||||||||||||
| compound | source | ||||||||||||||
| symmetry |
| ||||||||||||||
| crystal cell |
| ||||||||||||||
| method | X-Ray Diffraction | resolution | |||||||||||||
| ligand | EDO, GBS, GOL, PGE | enzyme |
| ||||||||||||
| Primary reference | Targeting enteropeptidase with reversible covalent inhibitors to achieve metabolic benefits., Sun W, Zhang X, Cummings MD, Albarazanji K, Wu J, Wang M, Alexander R, Zhu B, Zhang Y, Leonard J, Lanter J, Lenhard J, J Pharmacol Exp Ther. 2020 Oct 8. pii: jpet.120.000219. doi:, 10.1124/jpet.120.000219. PMID:33033171 | ||||||||||||||
| Data retrieval |
![]() |
| View 6ZOV in 3D |
Proteopedia, because life has more than 2D. |
| Structure-derived information |
| Sequence-derived information |
|
OCA© by Jaime Prilusky, 1996-2014,2022,2024 Bioinformatics Unit Weizmann Institute of Science |